Cargando…
Mir214-3p and Hnf4a/Hnf4α reciprocally regulate Ulk1 expression and autophagy in nonalcoholic hepatic steatosis
Macroautophagy/autophagy, a self-degradative process, regulates metabolic homeostasis in response to various stress conditions and is a therapeutic target for nonalcoholic fatty liver disease. We found that autophagic activity was inhibited as a result of a significant reduction in the expression of...
Autores principales: | Lee, Da-Hye, Park, So-Hyun, Ahn, Jiyun, Hong, Seung Pyo, Lee, Eunyoung, Jang, Young-Jin, Ha, Tae-Youl, Huh, Yang Hoon, Ha, Seung-Yeon, Jeon, Tae-Il, Jung, Chang Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496708/ https://www.ncbi.nlm.nih.gov/pubmed/33078654 http://dx.doi.org/10.1080/15548627.2020.1827779 |
Ejemplares similares
-
6-Gingerol Ameliorates Hepatic Steatosis via HNF4α/miR-467b-3p/GPAT1 Cascade
por: Ahn, Jiyun, et al.
Publicado: (2021) -
Liver fat storage is controlled by HNF4α through induction of lipophagy and is reversed by a potent HNF4α agonist
por: Lee, Seung-Hee, et al.
Publicado: (2021) -
A potent HNF4α agonist reveals that HNF4α controls genes important in inflammatory bowel disease and Paneth cells
por: Lee, Seung-Hee, et al.
Publicado: (2022) -
Species-Specific Differences in the Expression of the HNF1A, HNF1B and HNF4A Genes
por: Harries, Lorna W., et al.
Publicado: (2009) -
Long-term oral administration of an HNF4α agonist prevents weight gain and hepatic steatosis by promoting increased mitochondrial mass and function
por: Veeriah, Vimal, et al.
Publicado: (2022)